136 related articles for article (PubMed ID: 2547465)
1. Pharmacokinetics of lisinopril (IV/PO) in healthy volunteers.
Beermann B; Till AE; Gomez HJ; Hichens M; Bolognese JA; Junggren I
Biopharm Drug Dispos; 1989; 10(4):397-409. PubMed ID: 2547465
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of lisinopril.
Beermann B
Am J Med; 1988 Sep; 85(3B):25-30. PubMed ID: 2844083
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
McLean AJ; Drummer OH; Smith HJ; Froomes P; McNeil JJ
J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses.
Gómez-Díez M; Muñoz A; Caballero JM; Riber C; Castejón F; Serrano-Rodríguez JM
Res Vet Sci; 2014 Aug; 97(1):105-10. PubMed ID: 24972864
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
Sica DA; Cutler RE; Parmer RJ; Ford NF
Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
Kelly JG; Doyle GD; Carmody M; Glover DR; Cooper WD
Br J Clin Pharmacol; 1988 Dec; 26(6):781-6. PubMed ID: 2853960
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
Bendtsen F; Henriksen JH
J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure.
Till AE; Dickstein K; Aarsland T; Gomez HJ; Gregg H; Hichens M
Br J Clin Pharmacol; 1989 Feb; 27(2):199-204. PubMed ID: 2540786
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses.
Gardner SY; Atkins CE; Sams RA; Schwabenton AB; Papich MG
J Vet Intern Med; 2004; 18(2):231-7. PubMed ID: 15058776
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach.
Ribeiro W; Muscará MN; Martins AR; Moreno H; Mendes GB; de Nucci G
Eur J Clin Pharmacol; 1996; 50(5):399-405. PubMed ID: 8839663
[TBL] [Abstract][Full Text] [Related]
11. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men.
Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y
Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure.
Johnston D; Duffin D
Am J Cardiol; 1992 Oct; 70(10):151C-153C. PubMed ID: 1329474
[No Abstract] [Full Text] [Related]
13. The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide.
Swaisland AJ
J Hum Hypertens; 1991 Dec; 5 Suppl 2():69-71. PubMed ID: 1665181
[TBL] [Abstract][Full Text] [Related]
14. Switching from enalapril to lisinopril.
Brouard A; Conort O; Oliary J; Terrier JL
Am J Hosp Pharm; 1991 Dec; 48(12):2605. PubMed ID: 1667565
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic comparative study of zofenopril and enalapril in healthy volunteers.
Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Crivelli F; Ismaili S; Giusti A; Uhr MR
Arzneimittelforschung; 2002; 52(4):233-42. PubMed ID: 12040965
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor binding.
Jackson B; Cubela R; Sakaguchi K; Johnston CI
Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):343-7. PubMed ID: 2822313
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
Hayes PC; Plevris JN; Bouchier IA
J Hum Hypertens; 1989 Jun; 3 Suppl 1():153-8. PubMed ID: 2550638
[TBL] [Abstract][Full Text] [Related]
18. Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis.
Matalka K; Arafat T; Hamad M; Jehanli A
Fundam Clin Pharmacol; 2002 Jun; 16(3):237-44. PubMed ID: 12165071
[TBL] [Abstract][Full Text] [Related]
19. Lisinopril pharmacokinetics in chronic renal failure.
Jackson B; Cubela RB; Conway EL; Johnston CI
Br J Clin Pharmacol; 1988 Jun; 25(6):719-24. PubMed ID: 2849471
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum ACE inhibition to oral dose of enalapril in normotensive volunteers.
Rouini M; Hamidi M; Ghayoumi A; Ismailpour A
J Clin Pharm Ther; 2002 Apr; 27(2):121-6. PubMed ID: 11975696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
